(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
4 Dazzling And Well known Island Objections In US - 2Avoid Slam: Exploring the Pickup Truck Transformation
- 3Opening Achievement: 8 Methodologies for Compelling Using time productively
- 4Why this Iranian island looks like Mars after it rains
- 5I'm an 83-year-old yoga instructor. I'm not your typical grandma — I still work to feel fulfilled and supplement my Social Security.
- Jeff Bezos’ Blue Origin launches landmark Mars mission in New Glenn rocket’s first big test
- Kids with smartphones by age 12 are at higher risk of health issues, study finds
- Famous Versatile Brands: Your Decision
- The Secret Side of Italy: 12 Underrated Destinations Locals Don’t Want Tourists to Find
- 6 Famous Urban communities for Shopping on the planet
- Vote in favor of the Web-based Work out schedule to Keep You Fit and Sound
- Would you ever turn to AI for companionship? 6% of Americans say they could — or already have.
- It's been 20 years since MTV's golden couple split. These producers saw it all unravel.
- Top Music and Dance Celebration: Which One Gets You Going?
